The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.
December 06, 2012
November 06, 2012
Hospitalized heart failure patients who received the drug, serelaxin, in a phase III clinical trial had fewer disease symptoms and as a group experienced 37 percent fewer deaths over six months, according to results of a new study.
May 04, 2012
Academic medical centers can play a larger role in drug development and testing, according to an FDA official, who says there is a need for better strategies to identify winners, minimize costs and reduce failures during drug development.
June 24, 2011
Tina Brock, who recently became associate dean of teaching and learning in the UCSF School of Pharmacy, offers her perspective on the science of education, the importance of interprofessional learning and teaching future pharmacists.
May 05, 2011
UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
March 28, 2011
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble issued an update on the school's accomplishments, faculty awards and other campus news.
February 03, 2011
UCSF neurosurgeons and an MRI physicist have pioneered a faster, more accurate and less invasive surgical technique for treating patients with movement disorders, potentially changing the future of neurosurgery.
December 15, 2010
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
December 02, 2010
UCSF Chancellor Sue Desmond-Hellmann named campus leader Renee Navarro, past director of academic diversity, as the University’s first vice chancellor of diversity and outreach.
November 10, 2010
Paul Ortiz de Montellano has been appointed associate dean of research in the UCSF School of Pharmacy, a key advisor to the dean on campus, national and international science opportunities issues and trends.